Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Report – Research, Industry Analysis Reports and Market Demands

Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Diabetic Retinopathy (DR) Artificial Intelligence Screening System by Type
- 1.3.1 Overview: Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value Market Share by Type in 2023
- 1.3.3 Hardware
- 1.3.4 Software
1.4 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market by Application
- 1.4.1 Overview: Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Medical Institutions
- 1.4.3 Great Health Scene
1.5 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size & Forecast
1.6 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast by Region
- 1.6.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region, (2019-2030)
- 1.6.3 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Prospect (2019-2030)
- 1.6.4 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Prospect (2019-2030)
- 1.6.6 South America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Prospect (2019-2030)

2 Company Profiles

3 Market Competition, by Players

3.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Diabetic Retinopathy (DR) Artificial Intelligence Screening System by Company Revenue
- 3.2.2 Top 3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players Market Share in 2023
- 3.2.3 Top 6 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players Market Share in 2023
3.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market: Overall Company Footprint Analysis
- 3.3.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market: Region Footprint
- 3.3.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market: Company Product Type Footprint
- 3.3.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value and Market Share by Type (2019-2024)
4.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

5.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value Market Share by Application (2019-2024)
5.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Forecast by Application (2025-2030)

6 North America

6.1 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Type (2019-2030)
6.2 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application (2019-2030)
6.3 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country
- 6.3.1 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Country (2019-2030)
- 6.3.2 United States Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 6.3.3 Canada Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)

7 Europe

7.1 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Type (2019-2030)
7.2 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Application (2019-2030)
7.3 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country
- 7.3.1 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Country (2019-2030)
- 7.3.2 Germany Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 7.3.3 France Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 7.3.5 Russia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 7.3.6 Italy Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)

8 Asia-Pacific

8.1 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region
- 8.3.1 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Region (2019-2030)
- 8.3.2 China Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 8.3.3 Japan Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 8.3.5 India Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 8.3.7 Australia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)

9 South America

9.1 South America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Type (2019-2030)
9.2 South America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Application (2019-2030)
9.3 South America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country
- 9.3.1 South America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)

10 Middle East & Africa

10.1 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country
- 10.3.1 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)
- 10.3.4 UAE Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size and Forecast (2019-2030)

11 Market Dynamics

11.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Drivers
11.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Restraints
11.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Industry Chain
12.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Upstream Analysis
12.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Midstream Analysis
12.4 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

Diabetic retinopathy (DR) represents a major cause of visual impairment in developed countries. The ever-growing incidence of DR and its complications necessitates new strategies to screen patients, prevent complications and optimize management. For this reason, DR is a major target of AI-based models, especially those that can be used for large-scale screening. AI models should recognize DR-related alterations, such as haemorrhages, exudates, cotton wool spots and neovascularization; and, starting from fundus images, establish the presence or absence of DR, and grade it according to the conventional DR grading scales.
According to our (Global Info Research) latest study, the global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market size was valued at US$ 89.3 million in 2023 and is forecast to a readjusted size of USD 6525 million by 2030 with a CAGR of 82.8% during review period.
Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy.
This report is a detailed and comprehensive analysis for global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market size and forecasts, in consumption value ($ Million), 2019-2030
Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diabetic Retinopathy (DR) Artificial Intelligence Screening System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Diabetic Retinopathy (DR) Artificial Intelligence Screening System market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Diabetic Retinopathy (DR) Artificial Intelligence Screening System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hardware
Software
Market segment by Application
Medical Institutions
Great Health Scene
Market segment by players, this report covers
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Diabetic Retinopathy (DR) Artificial Intelligence Screening System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, with revenue, gross margin, and global market share of Diabetic Retinopathy (DR) Artificial Intelligence Screening System from 2019 to 2024.
Chapter 3, the Diabetic Retinopathy (DR) Artificial Intelligence Screening System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Diabetic Retinopathy (DR) Artificial Intelligence Screening System market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetic Retinopathy (DR) Artificial Intelligence Screening System.
Chapter 13, to describe Diabetic Retinopathy (DR) Artificial Intelligence Screening System research findings and conclusion.

Buy now